A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dabrafenib Impurity 17 - Request Quote

Picture of Dabrafenib Impurity 17

Dabrafenib Impurity 17

SZ CAT No:SZ-D120031
CAS No
NA
Mol.F.
C23H19F3N4O3S2
Mol.Wt.
520.5
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Dabrafenib Impurity 17 is chemically N-(3-(2-(Tert-butyl)-5-(2-hydroxypyrimidin-4-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide. Dabrafenib Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Dabrafenib Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Dabrafenib Impurity 17

Purchase Dabrafenib Impurity 17

Dabrafenib Impurity 17 suppliers

Dabrafenib Impurity 17 manufacturers

Dabrafenib Impurity 17 price

Order Dabrafenib Impurity 17

Enquire Dabrafenib Impurity 17

Dabrafenib Impurity 17 cost

Dabrafenib Impurity 17 Supplier

Dabrafenib Impurity 17 Distributor

Dabrafenib Impurity 17 for Method Validation

Dabrafenib Reference Standard

Dabrafenib Impurity 17 for ANDA Filing

Dabrafenib Impurity 17 for Forced Degradation Studies

Dabrafenib Impurity 17 Identification Standards

Dabrafenib Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,